Methylphenidate is a drug commonly used for treating attention deficit hyperactivity disorder (ADHD). It is the active ingredient in Ritalin, Ritalin SR, Ritalin LA, Concerta, Daytrana, Metadate, Metadate CD, Metadate ER, and Methylin. There are generic versions also. Since the summer there has been a shortage of methylphenidate generic and brand name products. A similar shortage is affecting supply of amphetamine salts (Adderall, Adderall XR).
The shortage is due to supply issues associated with the active ingredient; uneven product distribution; and not enough finished product to meet demand. Some reports suggested that shortage of the active ingredient was due to increased demand and the DEA is unable to release active ingredient fast enough. Regardless of the reason the pain is real for patients, families and healthcare providers.
Here is the availability of methylphenidate products from the latest FDA drug shortage update dated 11/14/2011 and other sources. The phone number for each manufacturer is also included.
If this shortage impacts you here are some suggestions:
The good news is that some of these shortages are expected to resolve early 2012.
Amphetamine (Adderall) Salts Shortage